Virtu Financial LLC Omeros Corp Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	SELL	$2.88 - $4.89 $54,671 - $92,826	-18,983 Reduced 65.29%	10,091 $35,000
Q4 2023 Feb 26, 2024	BUY	$1.08 - $3.63 $31,399 - $105,538	29,074 New	29,074 $95,000
Q4 2022 Feb 15, 2023	BUY	$1.75 - $3.96 $60,996 - $138,025	34,855 New	34,855 $79,000
Q1 2022 May 17, 2022	SELL	$5.07 - $7.2 $307,505 - $436,694	-60,652 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$5.67 - $8.54 $343,896 - $517,968	60,652 New	60,652 $390,000
Q4 2020 Feb 24, 2021	SELL	$10.14 - $15.19 $137,031 - $205,277	-13,514 Closed	0 $0
Q3 2020 Dec 11, 2020	SELL	$9.57 - $21.32 $83,804 - $186,699	-8,757 Reduced 39.32%	13,514 $137,000
Q2 2020 Aug 07, 2020	BUY	$12.21 - $16.99 $271,928 - $378,384	22,271 New	22,271 $328,000
Q1 2019 Apr 12, 2019	SELL	$11.65 - $17.72 $264,967 - $403,023	-22,744 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$10.72 - $16.73 $32,395 - $50,558	3,022 Added 15.32%	22,744 $253,000
Q1 2018 May 14, 2018	BUY	$9.0 - $20.16 $177,498 - $397,595	19,722 New	19,722 $220,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $647M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.